|
Peer Reviewed External Grants and Contracts
CARDIOLOGY
Principle Investigator |
Project |
Funding Agency |
Basta, Magdy |
Evaluation of Resynchronization Therapy for Heart Failure |
St. Jude Medical |
Basta, Magdy |
Tolerance and Efficacy Study of RSD1235 |
Fujisawa |
Basta, Magdy |
Canadian Atrial Fibrillation Evaluation Study |
Guidant Canada |
Basta, Magdy |
Canadian Registry Of ICD Implant Testing Procedures |
Guidant Canada |
Basta, Magdy |
Lead LIFE study-Longterm Integrity Followup Evaluation |
Guidant Canada |
Bata, Iqbal |
The WEST Study |
Canadian Vigour Centre |
Bata, Iqbal |
Early Glycoprotein IIb/iia Inhibition |
Millennium Pharmaceuticals |
Bata, Iqbal |
Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial |
Hamilton Health Sciences Corporation |
Bata, Iqbal |
Focus on Coronary Unstable Syndromes |
Aventis Pharma |
Bata, Iqbal |
Tilarginine Acetate Injection Study |
Actelion Pharmaceuticals |
Cox, Jafna |
Global Risk Factor Assessment and Management Primary Prevention Initiative |
Pfizer Canada |
Cox, Jafna |
A Novel Approach to Cardiovascular Health by Optimizing Risk Management |
Pfizer Canada |
Cox, Jafna |
Pilot Study on the Efficacy of a specialized Thrombosis clinic |
Dupont |
Cox, Jafna |
CCORT Project #5 Physician Perceptions Concerning Barriers to Complying with Quality Indicators Evaluated in Cardiac Report Cards |
CIHR |
Cox, Jafna |
Improving Cardiovascular Outcomes in Nova Scotia |
Merck |
Crowell, Richard |
Evaluation Of The Anti-anginal Efficacy And Safety Or Oral Administration Of Ivabradine |
Servier Canada |
Horacek, Milan |
|
Phillips Medical System |
Howlett, Jonathan |
A Strategy of Telehome Care for Management of Congestive Heart Failure |
Cardiome Pharma |
Howlett, Jonathan |
Surgical Treatment for Ischemic Heart Failure Trial |
Astra Zeneca |
Howlett, Jonathan |
HF-Action-for Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training |
National Institute of Health |
Howlett, Jonathan |
Study of a 2000mg Oral Dose of PG-116800 Given as the Sodium Salt (PG-530742) Twice Daily for 90 Days |
National Heart, Lung & Blood Institute |
Howlett, Jonathan |
Follow-up Serial Infusion of Natrecor |
Procter & Gamble |
Howlett, Jonathan |
Trial Evaluating the Role of Growth Hormone Therapy Compared to Standard Care |
Novartis |
Howlett, Jonathan |
Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide |
Canadian Cardiovascular Collaboration |
Love, Michael |
Primary PCI Program |
Ottawa Heart Institute Research Corporation |
Love, Michael |
A Study to evaluate the effect of Rosuvastatin on intravascular ultrasound-derived coronary atheroma burden |
Eli Lilly |
Quraishi, Ata |
A Comparison Of CS-747 And Clopidogrel |
St. Jude Medical |
Quraishi, Ata |
Safety and Efficacy of Enoxaparin in PCI Patients |
Eli Lilly Canada |
Rajda, Miroslaw |
N-Terminal Pro-Brain Peptide for the Diagnosis of Heart Failure and the Prediction of Clinical Outcomes |
Aventis |
Rajda, Miroslaw |
Study Evaluating The Overall Efficacy And Safety Including The Effect On Renal Function Of Sirolimus |
Roche Diagnostics Canada |
Rajda, Miroslaw |
BEAUTIFUL Study |
Hoffman LaRoche |
Sapp, John |
RAFT Study |
Servier |
Sapp, John |
ACTIVE Study |
CIHR |
Sapp, John |
Study Evaluating the Value of a Therapeutic Strategy to Restore and Maintain Simus Rhythm |
Sanofi Synthelabo |
Sapp, John |
The Electrode Configuration Study |
CIHR |
Sapp, John |
|
HSFNS |
Sapp, John |
|
Biosense Webster |
Title, Lawrence |
Evaluation of the Fixed Combination Torcetrapib/Atorvastatin, Administered Orally QD, Compared with Atorvastatin Alone |
Guidant Canada |
Title, Lawrence |
COURAGE Trial |
Pfizer |
Title, Lawrence |
Vein-Coronary Atherosclerosis and Rosiglitazone After Bypass Surgery Trial |
Veterans Affairs |
Title, Lawrence |
ERASE Trial |
GlaxoSmithKline |
Title, Lawrence |
AIM-HIGH Trial |
CSL Limited |
Title, Lawrence |
Effect of Glucose Loading with or without Antioxidant Vitamins on Endothelial Function –D Glucose |
National Heart, Lung & Blood Institute |
Title, Lawrence |
Coronary Artery Intravascular Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin Alone |
AtheroGenics |
Title, Lawrence |
Ischemia Management with Accupril post Bypass Graft via. Inhibition of Converting Enzyme |
Pfizer Canada |
Title, Lawrence |
Occulded Artery Trial & Total Occlusion Study of Canada |
Parke Davis |
Title, Lawrence |
HOPE TOO |
National Heart, Lung & Blood Institute |
Title, Lawrence |
Firefighters and Their Endothelium |
MRC |
Title, Lawrence |
Study of the Sirolimus-Coated By Velocity Balloon-Expandable Stent |
CIHR |
Title, Lawrence |
Study of the Efficacy & Safety of Long Term Administration of Nateglinide and Balsartan |
Cordis |
Title, Lawrence |
Reduction of Vascular Inflammation and Coronary Atherosclerosis with AGI-1067 |
Novartis |
Townley, Richard |
RESTOR-CHF Study |
AtheroGenics |
CRITICAL CARE
Principle Investigator |
Project |
Funding Agency |
Hall , Richard |
Study of E5564, A Lipid A Antagonist |
Eisai Medical Research |
Hall , Richard |
Trial of Prophylactic Heparin in Patients who are Undergoing Treatment with Drotrecogin Alfa (Activated) |
Eli Lilly Canada |
Hall , Richard |
Study of the Safety and LIPOS Study |
GlaxoSmithKline |
Hall , Richard |
|
Tanox |
Hall , Richard |
VALID Study |
ALTANA Pharma |
DERMATOLOGY
Principle Investigator |
Project |
Funding Agency |
Langley, Richard |
The Use of Kineret in the Treatment of FCU |
Atlantic Provinces Dermatology Association |
ENDOCRINOLOGY
Principle Investigator |
Project |
Funding Agency |
Kaiser, Stephanie |
Canadian Multicentre Osteoporosis Study |
Health Canada |
Kaiser, Stephanie |
An Evaluation to Compare Lipid lowering effects of rosuvastatin and atorvastain |
Astra Zeneca |
Kaiser, Stephanie |
Study to Determine the Efficacy and Safety of Intravenous Zoledronic Acid 5 mg Annually Compared to Oral Alendronate 70 mg Weekly |
Novartis |
Kaiser, Stephanie |
Compliance with and Acceptance of Teriparatide Pen Use |
Eli Lilly Canada |
Rowe, Richard |
Diabetes Reduction with Ramipril & Rosiglitazone Medication |
CIHR |
Rowe, Richard |
Efficacy and Safety of EXUBERA (Inhaled Insulin) Compared with Subcutaneous Human Insulin Therapy |
Pfizer Canada |
Rowe, Richard |
Effects of Candesartan Cilexetil on Diabetic Retinopathy |
Astra Zeneca |
Ur, Ehud |
ACCORD Study |
National Heart, Lung & Blood Institute |
Ur, Ehud |
Primary Care Diabetes Case Management |
GlaxoSmithKline |
Ur, Ehud |
Study of rimonabant 20mg once daily |
Sanofi Synthelabo Canada |
Ur, Ehud |
Study to compare the durability of glucose lowering and preservation of pancreatic Beta-cell function of reosilitazone monotherapy compared to metformin or glyburide |
SmithKline Beecham |
Ur, Ehud |
Selenium and Vitamin E Cancer Prevention Trial |
Southwest Oncology Group |
Ur, Ehud |
Study to Evaluate the Effects of LANTUS (Insulin Glargine) Versus Standard Care and Omega-3 Fatty Acids vs. Placebo |
Aventis Pharma |
Ur, Ehud |
A Study to Compare the Efficacy and Safety of Pegvisomant to that of Sandostatin LAR® |
Pharmacia Canada |
Ur, Ehud |
The Long-term Safety And Tolerability Of Sandostatin LAR |
Novartis |
Ur, Ehud |
Study of Weight Reducing Effect and Safety of SR141716 |
Sanofi Synthelabo |
Ur, Ehud |
Evaluation of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib, Atorvastatin Administered Orally, Once Daily for 18 Weeks |
Pfizer Canada |
Ur, Ehud |
Study to Evaluate Treatment With A Combination of Pegvisomant Plus Sandostatin LAR, Pegvisomant (Alone) and Sandostatin LAR Alone |
Pfizer |
Ur, Ehud |
Study to investigate efficacy, safety, tolerability and pharmacokinetics of the DPPIV inhibitor RO0730699 |
Hoffman LaRoche |
Ur, Ehud |
Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapid (CP-529,414)/Atorvastatin, Compared with Atorvastatin Therapy Alone, and Fenofibrate Alone |
Pfizer Canada |
Ur, Ehud |
CanACTFAST Study |
Pfizer Canada |
Ur, Ehud |
Trial of Blood Pressure Lowering with a Fixed Dose Low-Dose Perindopril-Inadapamide Combination and Intensive Glucose Control with a Modified Release Gliclazide Based Regimen |
University of Montreal |
Ur, Ehud |
CAP Study |
Pfizer Canada |
Ur, Ehud |
Study of Sandostatin LAR in the Therapy of Patients with Moderately Severe or Severe non-proliferative diabetic retinopathy or low risk proliferative diabetic retinopathy |
Novartis |
Ur, Ehud |
Study of the efficacy and safety of long term administration of nateglinide and valsartan |
Boehringer Ingelheim |
Ur, Ehud |
Trial Comparing Efficacy and Safety of Insulin Determir Versus Insulin Glargine |
Novo Nordisk Canada |
Ur, Ehud |
Evaluation of Diabetic Retinopathy Progression |
Aventis Pharma |
GASTROENTEROLOGY
Principle Investigator |
Project |
Funding Agency |
Farina, Dana |
Study to Evaluate Different Dosing Regimens of Rabeprazole in Controlling Noctural Heartburn Symptoms |
Janssen Ortho |
Khaliq-Kareemi, Munaa |
Safety Study to Assess the Safety of Chronic Therapy with the Humanised Anti-TNF PEG Conjugate CDP870 400mg sc |
Celltech R&D Limited |
Khaliq-Kareemi, Munaa |
Study to Assess the Maintenance of Clinical Response to Humanised anti-TNF PEG Conjugate, CDP870 400 mg sc, |
Celltech R&D Limited |
Khaliq-Kareemi, Munaa |
Study to Assess the Safety of Re-Exposure After a Variable Interval and Subsequent Chronic Therapy with the Humanised Anti-TNF PEG Conjugate CDP870 400mg sc |
Celltech R&D Limited |
Leddin, Desmond |
MAGNETIC Healing of Patients After Treatment with Pantoprazole-Magnesium Dihydrate 80 mg o.d. in Comparison to Pantoprazole-Sodium Sesquilhydrate 40 mg o.d. |
ALTANA Pharma |
Leddin, Desmond |
Study to Determine the Efficacy and Safety of VSL#3 Probiotic Food Supplement Mixture |
Crohn’s & Colitis Found. Of Canada |
Leddin, Desmond |
Study to Evaluate Efficacy and Safety of Talnetant |
GlaxoSmithKline |
Leddin, Desmond |
Study of Antibiotic Associated G.I. Side-Effects |
Eli Lilly |
Love, Jonathan |
Safety and Efficacy of ALX-0600 |
Allelix |
Love, Jonathan |
A Pilot Study of the Safety and Efficacy of ALX-0600 |
Allelix |
MacIntosh, Donald |
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab |
Abbott Laboratories |
MacIntosh, Donald |
Study of the Safety and Efficacy of Intravenous Antegren |
Elan Pharmaceuticals |
MacIntosh, Donald |
Study of the Safety, Tolerability, and Efficacy of intravenous Antegren |
Elan Phamaceuticals and Abbott Laboratories |
MacIntosh, Donald |
Incidence of Post-ERCP pacreatitus in patients undergoing hydrophilic guide wire cannulation of the common bile duct versus standard cannulation with dye injection |
Boston Scientific Corporation |
MacIntosh, Donald |
Study to Assess the Efficacy and Safety of Omega-3 Fatty Acids |
John P. Robarts Research Institute |
Peltekian, Kevork |
Peg-INTRON Plus REBETOL |
Schering Canada |
Peltekian, Kevork |
Study To Explore The Benefit Of A Conversion From Twice A Day Administration Of Neoral To A Once A Day Administration And To Identify The C2 Ranges |
Novartis |
Peltekian, Kevork |
Study To Evaluate The Safety And Efficacy Of Celgosivir In Combination With Peginterferon Alfa-2b, With And Without Ribavirin For 12 Weeks |
Migenix Inc |
Peltekian, Kevork |
Study To Evaluate The Efficacy And Safety Of Albuferon In Combination With Ribavirin |
Human Resources Development Canada |
Peltekian, Kevork |
An Extension Protocol to Evaluate the Long Term Effects of Treatment with Peginterferon Alfa 2a or Roferon-A |
Hoffman LaRoche |
Peltekian, Kevork |
PEG-Intro Maintenance Therapy vs. an Untreated Control Group for Prevention of Progression of Fibrosis |
Schering Canada |
Phalen-Kelly, Kelly |
Will Disease Specific Teaching by an ERN Increase Patient Knowledge as Measure by the Crohn’s and Colitis Knowledge Score? |
Nursing |
Peterson, Theresa |
|
CIHR |
Turnbull, G.K. |
Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Multiple Doses and Dose Levels of DDP225 |
Dynogen Pharmaceuticals, Inc. |
Turnbull, G.K. |
Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Doses and Dose Levels of DDP733 |
Dynogen Pharmaceuticals, Inc. |
van Zanten, Sander |
A Prospective Study On The Use Of And Indications For Treatment With H2-Blcokers And Proton Pump Inhibitors In Nova Scotia |
Janssen Ortho and Canadian Digestive Health Foundation |
van Zanten, Sander |
HEARD Study |
Astra Zeneca |
van Zanten, Sander |
Association Between Proton Pump Inhibitors Or H2 Blockers Program |
Green Shield Canada |
van Zanten, Sander |
Study To Validate The Reflux Disease Questionnaire |
Astra Zeneca |
van Zanten, Sander |
Study, to Assess the Efficacy and Safety of Tegaserod (6mg BID) and Placebo |
Novartis |
van Zanten, Sander |
Study for up to 8 Weeks Treatment with AZD0865 25, 50, 75 mg and Esomeprazole 40 mg, Given Orally Once Daily |
Astra Zeneca |
van Zanten, Sander |
Registry of Patients Undergoing Endoscopic and/or Acid Suppression Therapy and An Outcomes Analysis |
Astra Zeneca |
van Zanten, Sander |
A retrospective review to assess the utilization of intravenous and oral proton pump inhibitors and histamine H2-receptor antagonists in Canadian hospitals |
Astra Zeneca |
van Zanten, Sander |
|
CIHR |
GENERAL MEDICINE
Principle Investigator |
Project |
Funding Agency |
Pollak, PT |
|
CIHR |
Pollak, PT |
|
NSHRF |
Pollack, PT |
|
HSFNS |
GERIATRIC MEDICINE
Principle Investigator |
Project |
Funding Agency |
MacKnight, Chris |
Study Examining the Efficacy and Safety of Memantine on Behavioural Symptoms |
Lundbeck Canada |
MacKnight, Chris |
Study Of VP4896 For The Treatment Of Mild-to-Moderate Alzheimer’s Disease |
Voyager Pharmaceutical |
MacKnight, Chris |
Study of the Efficacy and Safety of Alzhemed |
Neurochem |
MacKnight, Chris |
CIHR Special Recognition Award |
CIHR |
MacKnight, Chris |
Study of the Efficacy and Safety of Atorvastatin 80 mg plus an Acetylcholinesterase Inhibitor vs an Acetylcholinesterase Inhibitor Alone |
Pfizer Canada |
MacKnight, Chris |
Canadian Alzheimer’s Disease Quality Of Life Study |
CIHR |
MacKnight, Chris |
Study of the Effect of Daily Treatment with MPC-7869 on Measures of Cognitive and Global Function |
Myriad Pharmaceuticals |
MacKnight, Chris |
|
CIHR |
MacPherson, Kathleen |
Medications and Cognition |
Merck Frosst Canada |
Rockwood, Ken |
Qualitative Analysis of Galantamine CIBIC Data |
Janssen Ortho |
Rockwood, Ken |
VISTAR Study |
Janssen Ortho |
Rockwood, Ken |
A New Initiative in Knowledge Transfer for the Management of Frailty |
Merck Frosst Canada |
Rockwood, Ken |
Primary Pharmacologic Prevention of Alzheimer’s Disease |
Merck Frosst Canada |
Rockwood, Ken |
Alzheimer Research |
Merck |
Rockwood, Ken |
|
CIHR |
Rockwood, Ken |
|
Alzheimer Society of Canada |
Rockwood, Ken |
|
University of British Columbia |
HEMATOLOGY
Principle Investigator |
Project |
Funding Agency |
Anderson, David |
The Van Gogh-DVT Trial |
Sanofi Synthelabo |
Anderson, David |
Blood Surveillance Program |
Department of Health |
Anderson, David |
Study Comparing the Efficacy and Safety of Once-Weekly Subcutaneous SanOrg34006 with the combination of Heparin and Vitamin K antagonist |
Sanofi Synthelabo |
Anderson, David |
REVERSE Study |
CIHR |
Anderson, David |
The SOX Trial |
CIHR |
Anderson, David |
EINSTEIN Study |
Bayer AG |
Anderson, David |
Study to investigate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of SB 497115-GR |
GlaxoSmithKline |
Couban, Stephen |
Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotheraphy |
National Cancer Institute of Canada |
Couban, Stephen |
Study of Gemcitabine, Dexmethasone, and Cisplantin Compared with Dexamethasone, Cytarabine, and Cisplatin |
National Cancer Institute of Canada |
Couban, Stephen |
Trial of 3-weekly rhuMAb 2H7 |
Hoffmann La Roche |
Couban, Stephen |
Study of STI571 vs. Interferon-a Combined with Cytarabine |
Novartis |
Couban, Stephen |
GLEEM Study |
Novartis |
Couban, Stephen |
BEXXAR Study |
3M Pharmaceuticals |
Couban, Stephen |
Study of Novel Erythropoiesis Stimulating Protein |
Amgen Canada |
Fernandez, L.A. |
Study to Evaluate the Efficacy and Safety of Rituximab Plus Fludarabine and Cyclophosphamide vs. Fludarabine and Cyclophosphamide Alone |
Hoffmann La Roche |
Forrest, Donna |
Trial Comparing CVP + MabThera to Standard CVP chemotherapy |
Hoffman LaRoche |
McCarron, Bonnie |
Study on Extended BTE Prophylaxis |
Aventis Pharma |
McCarron, Bonnie |
Trial of Prophylactic Low Molecular Weight Heparin |
Ottawa Hospital |
McCarron, Bonnie |
Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin |
Pharmacia Canada |
Pleasance, Susan |
Quality End Of Life Care For Patients With Advanced Hematological Disorders And Their Caregivers |
CIHR |
Robinson, K. Sue |
Trial of ABVD Versus Stanford V+-Radiation therapy |
National Cancer Institute of Canada |
Robinson, K. Sue |
Trial Of Decitabine Versus Patient’s Choice With Physician Advice Of Either Supportive Care Or Low-Dose Cytarabine |
MGI Pharma, Inc |
Robinson, K. Sue |
Study To Investigate The Safety And Efficacy Of Treanda TM |
Salmedix |
Robinson, K. Sue |
Study of CLORETAZINE and Cytosine Arabinoside |
ICI Pharma ( Canada) |
Robinson, K. Sue |
Study to Investigate the safety and Activity of SDX-105 in Combination with Rituximab |
Salmedix |
White, Darrell |
Study of Thalidomide and Prednisone vs. No Further Therapy as Maintenance Following Autologous Stem Cell Transplant |
National Cancer Institute of Canada |
White, Darrell |
Revimid Extension. |
Celgene Corporation |
White, Darrell |
Study of Combination Thalidomide Plus Dexamethasone Therapy Versus Dexamethasone Therapy Alone |
Celgene Corporation |
White, Darrell |
Study of Tositumomab and Iodine 131-Tosituomab |
GlaxoSmithKline |
White, Darrell |
Protocol to provide Expanded Access to VELCADE |
Ortho Biotech |
White, Darrell |
Study of PS-341 in Patients with Untreated or Relapsed Waldenström’s Macroglobulinemia |
National Cancer Institute of Canada |
INFECTIOUS DISEASES
Principle Investigator |
Project |
Funding Agency |
Garduno, Rafael |
|
NSERC |
Haase, David |
HIV Clinical Trials Network |
Canadian HIV Trials Network |
Haase, David |
Determinants of Risk for Genital Chlamydia Infection in Canadian Street Youth |
Health Canada |
Haase, David |
Comparative Trial of a Novel CCR5 Antagonist, UK 427,857 in Combination with Zidovudine/Lamivudine Versus Efavirenz in Combination with Zidovudine/Lamivudine |
Pfizer |
Hatchette, Todd |
Diagnosis and Outcome of Q-Fever Community Acquired Pneumonia |
University of Alberta |
Johnston, Lynn |
Study of Subcutaneous Recombinant IL-2 in Patients with HIV-1 Infection and CD4 Cell counts>=350 mm3 |
Canadian HIV Trials Network |
Johnston, Lynn |
Comparative safety and efficacy study of Tipranavir boosted with low dose Ritonavir vs. genotypically defined Protease Inhibitior/Ritonavir |
Boehringer Ingelheim |
Johnston, Lynn |
Study of GT267-004 vs. Vancomycin, and GT267-004 vs. metrondinazole |
PPD Canada |
McNeil, Shelly |
Study to Evaluate the Efficacy and Safety of Micafungin vs. Liposomal Amphotericin B |
Fujisawa Canada |
McNeil, Shelly |
Comparative Study of Micafungin vs. Caspofungin As Antifungal Treatment |
Fujisawa Canada |
Schlech, Walter |
Population-based Survey of Febrile Gastroenteritis due to Listeria Monocytogenes in Nova Scotia |
ILSI North America |
Schlech, Walter |
SMART Study |
Canadian HIV Trials Network |
Schlech, Walter |
Assessing the Efficacy of Pneumococcal Vaccine in HIV Patients |
Providence Health Care Society |
Schlech, Walter |
Trial to Determine the Optimal Management of Patients with HIV Infection for Whom First and Second-Line Highly Active Antiretroviral Therapy Has Failed |
Canadian HIV Trials Network |
Schlech, Walter |
|
CIHR |
MEDICAL ONCOLOGY
Principle Investigator |
Project |
Funding Agency |
Colwell, Bruce |
Study of Intermittent Oral Cepecitabine with IV Oxaliplatin vs. Bolus and Continuous Infusion Fluorouracil/Intravenous Leucovorin with Intravenous Oxaliplatin |
Hoffmann La Roche |
Colwell, Bruce |
Study of Cetuximab and Best Supportive Care vs. Best Supportive Care |
National Cancer Institute of Canada |
Colwell, Bruce |
Study of Intermittent Oral Capecitabine with IV Oxaliplatin vs. Fluorouracil/Leucovorin as Adjuvant Therapy |
Hoffmann La Roche |
Davis , Mary |
Study of ZD1839 250 Mg and 500 Mg Versus Methotrexate |
Astra Zeneca |
Davis , Mary |
Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens |
Celgene Corporation |
Davis , Mary |
Study of BLP25 Liposome Vaccine |
Biomira Ivc. |
Dorreen, Mark |
Study of Adjuvant STI571 Versus Placebo |
National Cancer Institute of Canada |
Gallant, Julie |
A Pilot Project to Improve the Computer Database booking for Mammography services in Nova Scotia and Encourage preliminary database linkage of Gynecological and Breast Screening Services |
Health Infrastructure Support program |
Morzycki, Wojciech |
Study of ZD1839 (250mg Tablet) Plus Best Supportive Care vs. Placebo Plus Best Supportive Care |
Astra Zeneca |
Morzycki, Wojciech |
Trial Comparing Targretin Capsules/Cisplatin/Vinorelbine Versus Cisplatin/Vinorelbine |
Ligand Pharmaceuticals |
Rayson, Daniel |
Trial In Pancreatic Cancer Comparing (1) 5FU and D-L Folinic Acid vs. (2) Gemcitabine vs. (3) No Adjuvant Treatment |
National Cancer Institute of Canada |
Rayson, Daniel |
Trial of Caelyx and Cyclophosphamide |
Schering Canada |
Rayson, Daniel |
|
CARE |
Reyno, L. |
Trial of Sequenced EC + Filgrastim + Epoetin Alfa Followed by Paclitaxel vs. CEC as Therapy |
National Cancer Institute of Canada |
Reyno, L. |
Randomized Trial of Epoetin Alfa |
Ontario Clinical Oncology Group |
Skillings, J. |
A 28 day Oral Regimen of 5-Fluorouracil + 776C85 vs. Intravenous 5-Fluorouracil + Leucovorin as First-line therapy |
Glaxo |
Wood , Lori |
Study of Interferon Alfa Alone, CCI-779 Alone, and the Combination of Interferon Alfa and CCI-779 |
Wyeth Research |
Wood , Lori |
A SU011248 Treatment Protocol For Patients With Cytokine-Refarctory Metastatic Renal Carcinoma |
Pfizer |
Wood , Lori |
Study Evaluating the Efficacy and Safety of ABT-751 |
Abbott Laboratories |
Wood , Lori |
Study Evaluating the Safety and Efficacy of ABT-510 |
Abbott Laboratories |
Wood , Lori |
Trial of Interferon Alfa-2B or Interferon Alfa-2B Plus Bevacibumab |
Cancer Trials Support Unit |
Wood, Lori |
|
CARE |
Wood, Lori |
|
Cancer Care Nova Scotia |
NEPHROLOGY
Principle Investigator |
Project |
Funding Agency |
Keough-Ryan, Tammy |
Study to Evaluate the Efficacy and Safety of High Doses of Candesartan Cilexetil on the Reduction of Proteinuria |
Astra Zeneca |
Kiberd, Bryce |
Study comparing CellCept administered as a component of tacrolimus based immunosuppression therapy |
Hoffmann La Roche |
Kiberd, Bryce |
Cardiac Risk Reduction in the Kidney Transplant Clinic |
Fujisawa Canada |
Soroka, Steven |
Canadian Prevention of Renal and Vascular Endpoints Trial |
CIHR |
Soroka, Steven |
Study to Demonstrate the Efficacy and Safety of RO0503821 when Administered Intravenously |
Hoffman LaRoche |
Soroka, Steven |
Study Evaluating Once Monthly Darbepoetin Alfa Dosing |
Amgen Canada |
Soroka, Steven |
Chronic Kidney Disease Project |
Baxter Healthcare Corporation |
Soroka, Steven |
A study to evaluate the use of Rosuvastatin in subjects on regular haemodialysis |
Astra Zeneca |
Soroka, Steven |
An Active Safety Surveillance Plan to Conduct Serologic Testing for Anti-Erythropoietin Antibodies and Prospectively Monitor the Incidence of Pure Red Cell Aplasia (PRCA) |
Ortho Biotech |
Soroka, Steven |
Treatment Trial to Compare MICARDIS® 80mg vs. COZAAR® 100mg |
Boehringer Ingelheim |
Soroka, Steven |
Oral Calcimimtic Agent When Two Different Vitamin C Regimens are Used |
Amgen |
Soroka, Steven |
Trial to Reduce Cardiovascular Events with Aranesp Therapy |
Amgen Canada |
Storsley, Leroy |
The Long-Term Medical And Psychosocial Implications Of Becoming A Living Kidney Donor |
Canadian Institutes of Health Research |
West, Ken |
|
CIHR |
West, Ken |
|
CARE |
West, Ken |
|
Kidney Foundation |
West, Michael |
Pharmacokinetic/Pharmacodynamic Study of Replagal |
Transkaryotic Therapies |
West, Michael |
Study of the Safety and Efficacy of Fabrazyme |
Genzyme Corporation |
West, Michael |
Registry of Fabry Disease |
Transkaryotic Therapies |
NEUROLOGY
Principle Investigator |
Project |
Funding Agency |
Benstead, Timothy |
Treatment for Peripheral Neuropathy |
Eli Lilly Canada |
Benstead, Timothy |
Treatment for Symptomatic Peripheral Neuropathy |
Eli Lilly Canada |
Bhan, Virender |
Study to Evaluate the Safety, Tolerability and Efficacy of NBI-5788 |
Neurocrine Biosciences |
Bhan, Virender |
BEYOND Study |
Berlex Canada |
Bhan, Virender |
Study to Evaluate the Efficacy and Safety of Teriflunomide in Reducing the Frequency of Relapses and Delaying the Accumulation of Physical Disability |
Aventis Pharma |
Bhan, Virender |
ACHIEVE Study |
Teva Neuroscience |
Bhan, Virender |
Study to Evaluate the Safety and Efficacy of Rituximab |
Genentech |
Bhan, Virender |
Study of a Serum-Free Pre-Formulated Solution of AVONEX (Administered Intramuscularly |
Biogen |
Bhan, Virender |
Paediatric Demyelination Study |
Multiple Sclerosis Society of Canada |
Bhan, Virender |
Prospective Study Of The Clinical Epidemiology, Pathobiology, And Neuroimaging Features Of Canadian Children With Clinically Isolated Demyelinating Syndromes |
Multiple Sclerosis Society of Canada |
Bhan, Virender |
Dose Finding, Safety, Tolerability, and Efficacy Study of the Active Extension Phase |
Abbott Laboratories |
Darvesh, Sultan |
|
CIHR |
Darvesh, Sultan |
|
NSHRF |
Darvesh, Sultan |
|
HSFC |
Darvesh, Sultan |
|
Alzheimer Society of Canada |
Darvesh, Sultan |
|
Brain Tumor Foundation |
Grant, Ian |
Study of the Efficacy and Safety of AS-3201 |
Dainippon |
Grant, Ian |
Comparative Study of the Effect of Riluzole 50 mg bid on the Survival of ALS Subjects Compared to Historical Controls |
Aventis Pharma |
Gubitz, Gordon |
Study of Secondary Prevention of Small Subcortical Strokes |
National Institute of Health |
Gubitz, Gordon |
Confirmatory Efficacy And Safety Trial Of Activated Recombinant Factor VII |
Novo Nordisk Canada |
Kirby, Sarah |
Study of IV Edotecarin vs Temozolomide or Carmustine or Lomustine |
Pfizer Canada |
Murray, T. J. |
The Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis |
Multiple Sclerosis Society of Canada |
Murray, T. J. |
Controlled High Risk AVONEX MS Prevention Study |
Biogen |
Murray, T. J. |
Observational Study of Treatment with Betaseron for Early-Stage Relapsing-Remitting Multiple Sclerosis |
Berlex Canada |
Murray, T. J. |
Study to Determine the Safety & Efficacy of Natalizumab |
Biogen |
Murray , T.J. |
|
Music in Medicine |
Murray , T.J. |
|
NSHRF |
Phillips, Stephen |
Stroke Audit |
Department of Health |
Phillips, Stephen |
Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke |
Astra Zeneca |
Phillips, Stephen |
Registry of the Canadian Stroke Network |
Canadian Stroke Network |
Phillips, Stephen |
CHARISMA Trial |
Sanofi Synthelabo Canada |
Phillips, Stephen |
Cerebral Hemorrhage and NXY Treatment Study to Assess the Safety and Tolerability of 72 Hours IV Infusion of NXY-059 |
Astra Zeneca |
Phillips, Stephen |
The Economic Burden Of Ischemic Stroke In Canada |
Sunnybrook & Women’s College Health Sciences Centre |
Phillips, Stephen |
Study of the Efficacy and Safety of I.V. Clomethizole Compared to Placebo |
Astra |
Purdy, Allan |
Study To Assess the Efficacy, Tolerability and Safety of Oral Frovatriptan |
Vernalis Development |
Purdy, Allan |
Clinical Study Of Migraine Evolution |
GlaxoSmithKline |
Sadler, Mark |
Pregabalin BID Add-On Trial |
Pfizer Canada |
Sadler, Mark |
Study to Evaluate the Efficacy and Safety of Adjunctive Treatment with 3000 mg/day oral Levetiracetam |
Parexel |
Weaver, Donald |
|
NSERC |
Weaver, Donald |
|
Alzheimer Society of Canada |
Weaver, Donald |
|
NSHRF |
Weaver, Donald |
|
CIHR |
Weaver, Donald |
|
CFI |
Weaver, Donald |
|
AIF |
PHYSICAL MEDICINE & REHABILITATION
Principle Investigator |
Project |
Funding Agency |
Kirby, Lee |
|
CIHR |
Kirby, Lee |
|
CIHR |
Kirby, Lee |
|
CIHR |
Short, Christine |
Study to Evaluate Safety, Tolerability and Activity of Oral Fampridine-SR |
Acorda Therapeutics |
Short, Christine |
Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10mg B.I.D.) in Subjects with Multiple Sclerosis |
Acorda Therapeutics |
RESPIROLOGY
Principle Investigator |
Project |
Funding Agency |
Hernandez, Paul |
Effects of Home-Based versus Hospital-Based Outpatient Pulmonary Rehabilitation in Patients with COPD |
CIHR |
Hernandez, Paul |
Measurement of Exertional Dyspnea in the Clinical Setting in Patients with COPD |
Boehringer Ingleheim |
Hernandez, Paul |
Trial to Evaluate the Effect of Tiotropium Inhalation Capsules on the Magnitude of Exercise |
Boehringer Ingelheim |
Hernandez, Paul |
Efficacy and safety comparison of one year treatment of two doses (5ug (2 actuations of 2.5 ug) and 10ug (2 acutations of 5ug) of Tiotropium Inhalation Solution |
Boehringer Ingelheim |
Hernandez, Paul |
Study Of The Phosphodiesterase Type 5 Inhibitor Tadalafil |
Lilly ICOS LLC |
Hernandez, Paul |
Comparison of Treatment with ARIFLO to that of Placebo for Changes in Ventilatory Mechanics and Function |
GlaxoSmithKline |
Hernandez, Paul |
Asthma In Obese Subjects |
CIHR |
McIvor, Andrew |
Study to Investigate the Effect of 500 mcg Roflumilast Tablets o.d. vs. Placebo on Parameters Indicative of Hyperinflation |
ALTANA Pharma |
McIvor, Andrew |
Optimal Therapy of COPD to Prevent Exacerbations and Improve Quality of Life |
CIHR |
McIvor, Andrew |
Effect of Roflumilast on Exacerbation Rate |
Altana Pharma Group |
McIvor, Andrew |
Study of the Safety and Efficacy of Interferon gamma1b |
Intermune Inc |
McIvor, Andrew |
Study of the Efficacy & Safety of Tigecycline vs. Levofloxacin |
Wyeth Research |
Michael, R. |
Trial Evaluating Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients |
Corus Pharma, Inc. |
Michael, R. |
Dose Response Study to Determine the Optimum Dose of Dry Powder Mannitol Required to Generate Clinical Improvement |
Pharmaxis Ltd |
RHEUMATOLOGY
Principle Investigator |
Project |
Funding Agency |
Hanly, John |
Study of Neuropsychiatric Systemic Lupus Erythematosus |
CIHR |
Hanly, John |
Study of the Human anti-TNF monoclonal antibody D2E7 in Rheumatoid Arthritis Patients |
Knoll Pharma |
Hanly, John |
The Genes Study |
CIHR |
Hanly, John |
Trial to assess the efficacy and safety of mycophenolate mofetil in inducing response and maintaining remission |
Aspreva Pharmaceuticals |
Hanly, John |
|
CIHR |
Sutton, Evelyn |
Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab |
Abbott Laboratories |
|